United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded Jun 18, 2026 · Filed Jun 18, 2026

On Jun 18, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$541.55 for US$4.49M under a trading plan, leaving 45,172 shares. Filed Jun 18, 2026 (Form 4).

Sold
8,300 shares
Price
US$541.55 average (US$537.04 to US$551.74)
Value
US$4.49M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 18, 2026Common StockOption exercise8,300US$146.0353,472Direct
Jun 18, 2026Common StockSale1,715US$537.0451,757Direct
Jun 18, 2026Common StockSale958US$538.0350,799Direct
Jun 18, 2026Common StockSale1,305US$539.4249,494Direct
Jun 18, 2026Common StockSale798US$540.2548,696Direct
Jun 18, 2026Common StockSale950US$541.2647,746Direct
Jun 18, 2026Common StockSale160US$541.9547,586Direct
Jun 18, 2026Common StockSale480US$544.2647,106Direct
Jun 18, 2026Common StockSale157US$546.1546,949Direct
Jun 18, 2026Common StockSale881US$547.6546,068Direct
Jun 18, 2026Common StockSale496US$548.9145,572Direct
Jun 18, 2026Common StockSale400US$551.7445,172Direct

Source

View original at SEC

Related